Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the planned retirement of company co-founder Stephen Squinto, Ph.D., effective January 1, 2015.
Dr. Squinto currently serves as Executive Vice President, Chief Global Operations Officer. He co-founded Alexion in 1992 with Leonard Bell, M.D., the Company’s principal founder and current Chairman and Chief Executive Officer. Throughout his tenure, Dr. Squinto has been instrumental in building the Company into a global leader in the development, manufacturing and delivery of biotechnology therapeutics.
Help employers find you! Check out all the jobs and post your resume.
